Patents Assigned to Orient Europharma Co., Ltd.
  • Patent number: 11452681
    Abstract: A cosmetic composition to prevent and/or ameliorate skin aging and applications thereof are provided in the present disclosure and the cosmetic composition comprises cyclic phosphatidic acid and citrus flavonoids which is hesperidin and/or hesperetin wherein the preventing and/or ameliorating skin aging include, without limitation, promoting moisture retention of stratum corneum, promoting skin elasticity, increasing presence or elasticity of collagens and elastins in fibroblasts, increasing transfers of fibroblasts, promoting anti-oxidation, increasing generation of hyaluronic acid, alleviating wrinkles and skin textures, moderating melanin, reducing skin oil and preventing transepidermal water losses.
    Type: Grant
    Filed: July 23, 2020
    Date of Patent: September 27, 2022
    Assignee: ORIENT EUROPHARMA CO., LTD.
    Inventors: Chin-Chih Chiang, Mon-Jer Tsai
  • Publication number: 20150265682
    Abstract: The present invention is directed to therapeutic methods and compositions for treating type 1 diabetes in a subject comprising administering an effective amount of borapetoside A or C, or a pharmaceutically acceptable salt, metabolite, solvate or prodrug thereof, and insulin to said subject.
    Type: Application
    Filed: March 20, 2014
    Publication date: September 24, 2015
    Applicant: Orient Europharma Co., Ltd.
    Inventors: Ming-Jai Su, Shoei-Sheng Lee
  • Publication number: 20150265644
    Abstract: The present invention is directed to therapeutic methods and compositions for treating insulin resistant diabetes or diabetes with inflammation in a subject comprising administering an effective amount of borapetoside A, or a pharmaceutically acceptable salt, metabolite, solvate or prodrug thereof, to said subject.
    Type: Application
    Filed: March 20, 2014
    Publication date: September 24, 2015
    Applicant: Orient Europharma Co., Ltd.
    Inventors: Ming-Jai Su, Shoei-Sheng Lee